The Huberman Lab
The Huberman Lab

Transform Your Metabolic Health & Longevity by Knowing Your Unique Biology | Dr. Michael Snyder

My guest is Michael Snyder, PhD, professor of genetics at Stanford and an expert in understanding why people respond differently to various foods, supplements, behavioral and prescription interventions. We discuss how to optimize your health and lifespan according to what type of glucose responder y

Featured Speakers

Scicomm Media HostAndrew Huberman GuestMichael Snyder Guest

Topics Discussed

Episode Summary

Executive Summary: Andrew Huberman and Michael Snyder discuss how health is highly individualized: glucose responses, fiber tolerance, exercise timing, sleep, and even psychological interventions vary by person. Snyder argues that CGMs, wearables, blood micro-sampling, and multi-omics can identify subtypes of diabetes, aging, and inflammation, enabling personalized food, drug, and lifestyle choices.

Main Topics: Personalized glucose regulation and CGMs (Priority: 5/5): The conversation centers on how blood glucose responses differ dramatically across individuals and foods, making continuous glucose monitoring a practical tool for identifying personal triggers and healthy ranges. Subphenotypes of diabetes and insulin dysregulation (Priority: 5/5): Snyder explains that type 2 diabetes is not one condition but multiple subtypes involving muscle insulin resistance, beta-cell defects, hepatic resistance, and incretin defects, each with different lifestyle and drug implications. Meal timing, exercise timing, and glucose control (Priority: 4/5): They discuss how meal timing, post-meal walking, sleep timing, and morning vs afternoon exercise can alter glucose regulation, with effects depending on the person’s metabolic subtype. Fiber heterogeneity and microbiome interactions (Priority: 5/5): The episode breaks down fiber into distinct categories, showing that different fibers can lower cholesterol or inflammation in some people but not others, likely due in part to microbiome differences. Wearables, micro-sampling, and multi-omics for health tracking (Priority: 5/5): Snyder describes using smartwatches, CGMs, blood micro-sampling, genomics, proteomics, and metabolomics to build dense longitudinal health profiles and detect early disease. Organ aging, biological age, and actionable biomarkers (Priority: 4/5): Rather than a single biological age, Snyder emphasizes organ- or pathway-specific aging patterns that can be tracked and improved with targeted interventions. Psychological interventions, acupuncture, and environmental exposures (Priority: 4/5): The discussion expands beyond nutrition into mental health interventions, acupuncture, and air quality/microplastics, arguing that these also measurably affect physiology and should be studied with the same rigor.

Key Arguments: Glucose spikes are not inherently bad; brief, transient rises after food or exercise can be normal, while prolonged spikes are harmful. Different people respond differently to the same foods, so glycemic index charts are too crude for individual health decisions. Type 2 diabetes should be subdivided into mechanistic subtypes because treatment and lifestyle responses differ by subtype. Morning activity may improve next-day glucose in people with muscle insulin resistance, but exercise timing is not universal. Post-meal brisk walking can blunt glucose spikes and improve next-day glucose control. Fiber is not one thing; different fibers have different effects on cholesterol, inflammation, and glucose, and these effects depend on the person. The microbiome and genetics each contribute meaningfully to glucose regulation, but lifestyle remains the largest modifiable factor. Longitudinal baselines are crucial because trajectories and deviations matter more than single measurements. Wearables and micro-sampling can reveal early disease and physiological shifts before symptoms appear. Psychological interventions can produce measurable improvements in mental health and inflammatory markers, suggesting mind-body effects are biologically real. Air quality, pesticides, and microplastics are undermeasured environmental exposures that likely influence health and should be tracked more carefully.

Data Points: Healthy glucose range: 70-140 mg/dL - Rule-of-thumb range Snyder cites for healthy people after meals and during daily regulation. Diabetic glucose range target: 70-180 mg/dL - General target range Snyder mentions for people with diabetes. Normal fasting glucose: around 90 mg/dL - Approximate typical glucose level for healthy people. CGM wear duration: about 14 days - Typical period a continuous glucose monitor can be worn to observe food responses. Post-meal walk duration: 15-20 minutes - Brisk walking after eating can suppress glucose spikes. A1c diabetic threshold: 6.5 or over - Snyder cites the standard cutoff used to classify diabetes. A1c pre-diabetic range: 5.7 to 6.4 - Snyder cites the standard cutoff used to classify pre-diabetes. Weight change on GLP-1 therapy: 144 lb to 128 lb - Snyder describes his own weight loss after GLP-1 treatment. A1c change on GLP-1 therapy: 8.4 to 5.7 - Snyder reports his own improvement in glycemic control after GLP-1 treatment. Metamucil/arabinoxylan effect on cholesterol: about 25% reduction - In a crossover study, arabinoxylan substantially lowered cholesterol for many participants. Fiber intake recommendation for women: 25 g/day - Snyder cites recommended daily fiber intake. Fiber intake recommendation for men: 35 g/day - Snyder cites recommended daily fiber intake. Typical fiber intake: 12-15 g/day - He notes most people consume far less fiber than recommended. Lifespan heritability: about 16% - Snyder cites estimates that genetics explain a minority of lifespan variation in the general population. Microbiome contribution to glucose levels: 20-30% - He cites studies suggesting the microbiome explains a substantial fraction of glucose regulation. Genetic contribution to glucose levels: about 20% - He cites genetics as another meaningful but partial contributor to glucose regulation. Whole-body MRI cost: about $2,000 - Approximate cost Snyder mentions for a whole-body scan. PM2.5 in studio: 3 - Air quality reading from the device Snyder brought into the recording room. PM10 in studio: 4 - Air quality reading from the device Snyder brought into the recording room. Tony Robbins study size: almost 700 participants plus about 700 controls - Snyder describes a large observational study of immersive psychological intervention. Micro-sampling frequency in one study: every hour for 7 straight days - Snyder describes intensive self-monitoring with blood micro-sampling. Number of major health discoveries in early profiling study: 49 people - He says the longitudinal health study uncovered major pre-symptomatic findings in 49 participants. Age of longest-lived human: 122 years and some change - Snyder references the record lifespan as a rough upper bound.

Pivotal Quotes: "not everybody responds the same way to the same behavioral, drug, supplement, or other treatment designed to improve health span and lifespan" — Andrew Huberman: Opening framing of the episode’s central thesis about individual variability. "we're homeostatic systems" — Michael Snyder: Snyder explains why health must be understood as a multi-organ, multi-pathway balancing act rather than a single metric. "the physicians work for you, not the other way around" — Andrew Huberman: Discussion of whole-body MRI, baselines, and patient-driven health monitoring.

Implications: Listeners should think in terms of personal data, not averages: measure glucose, sleep, activity, and exposures; identify your own subtypes; and use targeted food, exercise, and medical strategies. The future of medicine is longitudinal, individualized, and AI-assisted.

🔓 Sign Up for Unlimited Episode Search

About The Huberman Lab

The Huberman Lab podcast is hosted by Andrew Huberman, Ph.D., a neuroscientist and tenured professor in the department of neurobiology, and by courtesy, psychiatry and behavioral sciences at Stanford School of Medicine. The podcast discusses neuroscience and science-based tools, including how our brain and its connections with the organs of our body control our perceptions, our behaviors, and our health, as well as existing and emerging tools for measuring and changing how our nervous system works. Huberman has made numerous significant contributions to the fields of brain development, brain function, and neural plasticity, which is the ability of our nervous system to rewire and learn new behaviors, skills, and cognitive functioning. He is a McKnight Foundation and Pew Foundation Fellow and was awarded the Cogan Award, given to the scientist making the most significant discoveries in the study of vision, in 2017. Work from the Huberman Laboratory at Stanford School of Medicine has been published in top journals, including Nature, Science, and Cell, and has been featured in TIME, BBC, Scientific American, Discover, and other top media outlets. In 2021, Dr. Huberman launched the Huberman Lab podcast. The podcast is frequently ranked in the top 10 of all podcasts globally and is often ranked #1 in the categories of Science, Education, and Health & Fitness.

View all episodes from The Huberman Lab